2009
DOI: 10.1007/s00216-009-3375-7
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a new co-crystal of salicylic acid and benzamide of pharmaceutical relevance

Abstract: Raman spectroscopy, X-ray powder diffraction/X-ray crystallography and differential scanning calorimetry have been used to study the phenomenon of co-crystal formation in stoichiometric mixtures of salicylic acid with benzamide. Raman spectroscopy was particularly useful for the characterization of the products and was used to determine the nature of the interactions in the co-crystals. It was observed that little change in the vibrational modes associated with the phenyl groups of the respective reactants too… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
20
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(22 citation statements)
references
References 30 publications
1
20
0
Order By: Relevance
“…Stable coamorphous systems have been prepared from low solubility drugs and small molecular mass amino acids (14) or neutral molecules capable of forming strong H-bonding such as saccharin (15) or nicotinamide (16). Although numerous successful plasticized formulations have been prepared using carboxylic acids (17)(18)(19)(20), plasticized co-amorphous dispersions prepared from crystalline drugs with polycarboxylic acids are rare. Moreover, no studies have addressed the use of carboxylic acid plasticizers (CAPs) in amorphization of solid crystalline drugs by employing solvent evaporation under vacuum as the method of preparation.…”
mentioning
confidence: 99%
“…Stable coamorphous systems have been prepared from low solubility drugs and small molecular mass amino acids (14) or neutral molecules capable of forming strong H-bonding such as saccharin (15) or nicotinamide (16). Although numerous successful plasticized formulations have been prepared using carboxylic acids (17)(18)(19)(20), plasticized co-amorphous dispersions prepared from crystalline drugs with polycarboxylic acids are rare. Moreover, no studies have addressed the use of carboxylic acid plasticizers (CAPs) in amorphization of solid crystalline drugs by employing solvent evaporation under vacuum as the method of preparation.…”
mentioning
confidence: 99%
“…Pharmaceutical cocrystallization is crystalline molecular complexes containing therapeutic molecules for the development of the active pharmaceutical ingredient (API) drugs [10,11]. Cocrystals are generally formed through noncovalent interaction bonds (primarily hydrogen bonding), π-π stacking, van der Waals interactions and other weak interactions [10][11][12].…”
Section: Salicylic Acid (H2mentioning
confidence: 99%
“…However, some other benzamide compounds act as potent Kv1.3 inhibitors and Kv1.3 ion channel blockers (Haffner, Thomson, Guo, Petrov et al, 2010;Haffner, Thomson, Guo, Schaller et al, 2010). Recently, Elbagerma et al (2010) investigated the formation of cocrystals from equimolar quantities of salicylic acid and benzamide for the enhancement of the physiochemical properties of the active pharmaceutical ingredient without changing the pharmaceutical activity.…”
Section: Introductionmentioning
confidence: 99%